摘要
目的:观察益气活血软坚解毒法治疗中晚期原发性肝癌的临床疗效。方法:选取来我院进行治疗的中晚期原发性肝癌患者80例,将患者进行随机分组,分为观察组和对照组两组,每组各40例患者。对照组患者采取肝动脉导管介入化疗方案进行治疗,观察组患者采取口服益气活血软坚解毒汤剂进行治疗。结果:观察组患者和对照组患者治疗后癌灶变化(CR+PR)较治疗前变化不显著,组间比较差异不具有统计学意义(P>0.05);观察组患者治疗后的肿瘤稳定率(CR+PR+NC)为70.0%显著高于对照组患者的45.0%,比较差异具有统计学意义(P<0.05)。观察组患者治疗后的神疲乏力、食欲不振、恶心呕吐、疼痛、腹胀等临床症状较对照组显著改善,比较差异具有统计学意义(P<0.05)。观察组治疗后的稳定率为80.0%显著高于对照组患者的50.0%,比较差异具有统计学意义(P<0.05)。结论:益气活血软坚解毒法治疗中晚期原发性肝癌,能够显著提高患者的肿瘤稳定率、显著改善患者的临床症状,显著提高患者的生存质量。
Objective:To observe the clinical efficacy the therapy of Yiqihuoxue Ruanjian Jiedu for advanced primary liver cancer. Methods: 80 patients were randomly divided into observation group and control group, 40 patients in each group. The control group received hepatic artery catheterization chemotherapy treatment, the observation group were taken orally the Yiqihuoxue Ruanjian Jiedu decoction. Results:The changes of foci (CR+PR) after treatment than before treatment did not change significantly, the difference between groups show no statistical significance (P〉0.05); tumor steady rate (CR+PR+NC) of 70.0% was significantly higher than 45.0%, the difference was statistically significant (P〈0.05). Conclusion:Yiqihuoxue Ruanjian Jiedu treatment for advanced primary liver cancer can significantly improve the stability of the cancer and clinical symptoms.
出处
《中医临床研究》
2015年第7期74-75,共2页
Clinical Journal Of Chinese Medicine
关键词
益气活血软坚解毒法治疗
中晚期
原发性肝癌
临床疗效
The Yiqihuoxue Ruanjian Jiedu treatment
Advanced
Hepatocellular carcinoma
Clinical efficacy